Form 4: Zai Lab Chief Legal Officer Reports Stock Transactions
SEC Form 4 Filing
Frazor Titus Edmondson III, Chief Legal Officer of Zai Lab Ltd, reports acquisition and disposal of American Depositary Shares (ADS) related to vesting of Restricted Share Units (RSUs).
Summary
- On April 1, 2025, Frazor Titus Edmondson III, the Chief Legal Officer of Zai Lab Ltd, acquired ADSs through the vesting of RSUs.
- Specifically, 2,671 ADSs vested from one RSU grant, 830 ADSs vested from another, and 13,757 ADSs vested from a third.
- On April 2, 2025, Mr. Edmondson sold 4,369 ADSs at a price of $35.894 per ADS to cover taxes associated with the vesting of the RSUs.
- Following these transactions, Mr. Edmondson directly owns 27,217 ADSs and holds rights to 47,446 additional ADSs through RSUs.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider transactions related to compensation. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Future Outlook
The reporting person will continue to receive ADSs as RSUs vest over the next several years, subject to continued service.
Industry Context
Form 4 filings are routine disclosures required by the SEC when company insiders, like the Chief Legal Officer, trade their company's stock. These filings provide transparency to the market regarding insider transactions.
Comparison to Industry Standards
- Similar filings are common across the pharmaceutical and biotech industries, with companies like Amgen, Gilead Sciences, and Biogen regularly reporting insider transactions.
- The vesting schedules and RSU grants are typical compensation practices used to align management's interests with those of shareholders.
- The sale of shares to cover taxes upon vesting is also a standard practice among executives receiving equity compensation.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.
- The disclosure provides transparency to shareholders regarding insider transactions, which can influence investor confidence.
Key Dates
| Date | Description |
|---|---|
| 04/01/2022 | First anniversary of the date of grant for 830 RSUs, vesting in equal annual installments over five years. |
| 04/01/2023 | First anniversary of the date of grant for 2,671 RSUs, vesting in equal annual installments over five years. |
| 04/01/2025 | Date of ADS acquisition through RSU vesting (2,671, 830, and 13,757 ADSs). |
| 04/01/2025 | First anniversary of the date of grant for 13,757 RSUs, vesting in equal annual installments over four years. |
| 04/02/2025 | Date of ADS disposal (4,369 ADSs sold at $35.894). |
| 04/03/2025 | Date of signature for the Form 4 filing. |
Keywords
Zai Lab, ZLAB, Form 4, ADS, American Depositary Shares, RSU, Restricted Share Units, Edmondson, Frazor Titus Edmondson III, Chief Legal Officer, Vesting, Acquisition, Disposal
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.